Home > Insider Trading > Filing (0001171843-19-007390)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
898437	Anika Therapeutics Inc.	ANIK	Surgical & Medical Instruments & Apparatus (3841)	043145961

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1572857	Sylvia Cheung	32 Wiggins Avenue Bedford MA 01730	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-11-06	35,000	$6.36	71,422	No	4	M	Direct
Common Stock	Disposition	2019-11-06	3,681	$60.48	67,741	No	4	F	Direct
Common Stock	Disposition	2019-11-08	20,000	$59.71	47,741	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2019-11-06	35,000	$0.00	35,000	$6.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-01-26	No	4	M	Direct

Footnotes

On November 6, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung exercised stock appreciation rights ("SARS") granted on January 26, 2010 vesting in four equal annual installments beginning January 26, 2011 and expiring on January 26, 2020.
Reflects 3,681 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 6, 2019.
On November 8, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung sold 20,000 shares in multiple trades ranging from $59.00 to $60.40, a portion of which sale covered the tax liability associated with the SARs exercise. The price reported above reflects the weighted average sale price. Ms. Cheung undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.